✦ LIBER ✦

Strategies for Managing Heparin Therapy in Patients with Antiphospholipid Antibody Syndrome

✍ Scribed by Dr. Trupti P. Mehta; Dr. Maureen A. Smythe; Dr. Joan C. Mattson

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Therapy in ESRD patients with antiphosph

✍ S Vaidya; R Sellers; K Gugliuzza; J Daller; J.C Fish 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 114 KB

Heparin therapy for the antiphospholipid

✍ Y. Gollin; C. Howard; R. Bahado-Singh; J. Garofalo; A. Arici; J. Copel 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 121 KB

Long-duration therapy with low molecular

✍ F. DENTALI; E. MANFREDI; M. CROWTHER; W. AGENO 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

Danaparoid versus heparin therapy in rec

✍ K. Katano; M. Sugiura 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 36 KB

Antiplatelet Factor 4—Heparin Antibodies

✍ Marta E. Martinuzzo; Ricardo R. Forastiero; Yolanda Adamczuk; Gonzalo Pombo; Lui 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 263 KB

Use of fondaparinux in a patient with an

✍ S. G. HOLTAN; S. K. KNOX; A. TEFFERI 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB